# Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

> **NCT01160120** · PHASE2 · COMPLETED · sponsor: **The HIV Netherlands Australia Thailand Research Collaboration** · enrollment: 100 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** generic FDC of TDF/3TC/EFV

## Key facts

- **NCT ID:** NCT01160120
- **Lead sponsor:** The HIV Netherlands Australia Thailand Research Collaboration
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-05
- **Final completion:** 2015-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160120, "Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01160120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*